Ultimate magazine theme for WordPress.

MediWound Ltd. (MDWD) Q1 2023 Earnings Call Transcript

- Get Paid To Use Facebook, Twitter and YouTube -

MediWound Ltd. (NASDAQ:MDWD) Q1 2023 Earnings Conference Call May 30, 2023 8:30 AM ET

Company Participants

Monique Kosse – LifeSci Advisors, IR

Ofer Gonen – Chief Executive Officer

Hani Luxenburg – Chief Financial Officer

Barry Wolfenson – Executive Vice President of Strategy & Corporate Development

Conference Call Participants

Josh Jennings – TD Cowen

Francois Brisebois – Oppenheimer

Michael Okunewitch – Maxim Group

Swayampakula Ramakanth – H.C. Wainwright


Good day everyone and welcome to MediWound’s First Quarter 2023 Earnings Call. Today’s conference is being recorded. At this time, I would like to turn the floor over to Monique Kosse of LifeSci Advisors. Ma’am, please go ahead.

Monique Kosse

Thank you, Operator, and welcome, everyone. Earlier today, MediWound issued a press release announcing financial results for the first quarter ended March 31, 2023. You may access that release on the company’s website under the Investors tab.

With us today are Ofer Gonen, Chief Executive Officer of MediWound; Hani Luxenburg, Chief Financial Officer; and Barry Wolfenson, Executive Vice President of Strategy & Corporate Development. Following our prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session, relating to MediWound’s expected future performance, future business prospects or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995.

Although the company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, actual outcomes and results are subject to risks and uncertainties and could differ materially from those forecast due to the impact of many factors beyond the control of MediWound.

The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events or otherwise. Participants are directed to


Source link

Comments are closed.